Revelation Biosciences Inc (REVB)
Revelation Biosciences Market Cap: 3.168M for May 16, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 15, 2024 | 3.184M |
May 14, 2024 | 3.013M |
May 13, 2024 | 3.004M |
May 10, 2024 | 3.364M |
May 09, 2024 | 3.592M |
May 08, 2024 | 3.641M |
May 07, 2024 | 3.886M |
May 06, 2024 | 3.837M |
May 03, 2024 | 3.87M |
May 02, 2024 | 3.837M |
May 01, 2024 | 3.511M |
April 30, 2024 | 3.441M |
April 29, 2024 | 3.462M |
April 26, 2024 | 3.560M |
April 25, 2024 | 3.494M |
April 24, 2024 | 3.413M |
April 23, 2024 | 3.380M |
April 22, 2024 | 3.347M |
April 19, 2024 | 3.658M |
April 18, 2024 | 3.658M |
April 17, 2024 | 3.511M |
April 16, 2024 | 3.119M |
April 15, 2024 | 2.98M |
April 12, 2024 | 3.396M |
April 11, 2024 | 3.788M |
Date | Value |
---|---|
April 10, 2024 | 3.772M |
April 09, 2024 | 3.968M |
April 08, 2024 | 4.246M |
April 05, 2024 | 4.360M |
April 04, 2024 | 4.442M |
April 03, 2024 | 4.246M |
April 02, 2024 | 4.229M |
April 01, 2024 | 4.344M |
March 28, 2024 | 4.474M |
March 27, 2024 | 3.968M |
March 26, 2024 | 4.246M |
March 25, 2024 | 3.903M |
March 22, 2024 | 3.87M |
March 21, 2024 | 4.001M |
March 20, 2024 | 3.968M |
March 19, 2024 | 3.723M |
March 18, 2024 | 3.903M |
March 15, 2024 | 0.9553M |
March 14, 2024 | 0.9355M |
March 13, 2024 | 1.031M |
March 12, 2024 | 1.237M |
March 11, 2024 | 1.332M |
March 08, 2024 | 1.348M |
March 07, 2024 | 1.348M |
March 06, 2024 | 1.189M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Cardiff Oncology Inc | 167.49M |
Ocular Therapeutix Inc | 973.48M |
Ocugen Inc | 506.94M |
Cue Biopharma Inc | 84.64M |
Solid Biosciences Inc | 351.54M |
Market Cap Related Metrics
Price to Book Value | 0.3344 |
Price | 1.94 |
Earnings Yield | -1.59K% |